Long-Term Outcomes of Helper Peptide Vaccination for Metastatic Melanoma

Podobne zapisy

• Antibody response to melanoma helper-peptide vaccine correlates with survival
  od: Olson, Walter C, i wsp.
  Wydane: (2013)
• Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine
  od: Hu, Yinin, i wsp.
  Wydane: (2014)
• Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival
  od: Reed, Caroline M., i wsp.
  Wydane: (2015)
• A Randomized Phase II Trial of Multi-epitope Vaccination with Melanoma Peptides for Cytotoxic T-Cells and Helper T-Cells for Patients with Metastatic Melanoma (E1602)
  od: Slingluff, Craig L., i wsp.
  Wydane: (2013)
• Randomized Multicenter Trial of the Effects of Melanoma-Associated Helper Peptides and Cyclophosphamide on the Immunogenicity of a Multipeptide Melanoma Vaccine
  od: Slingluff, Craig L., i wsp.
  Wydane: (2011)